Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00230620 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 250 to 1000 Primary completion date: Nov 2018 to Apr 2030 · Completion date: Nov 2020 to Apr 2030 · Study description expanded, about 53 wordsv4 Show 3 more changesShow less
    • Primary completion date: Nov 2018 to Apr 2030
    • Completion date: Nov 2020 to Apr 2030
    • Study description expanded, about 53 words

    See this version in full on ClinicalTrials.gov ↗

  2. Primary completion date: Nov 2018 Completion date: Nov 2020v3 Show 1 more changeShow less
    • Completion date: Nov 2020
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine genes involved in the vascular dysplasia Hereditary haemorrhagic telangiectasia i(HHT)
Trial Details
NCT Number NCT00230620
Lead Sponsor Imperial College London
Collaborators: British Heart Foundation
Conditions Telangiectasia, Hereditary Hemorrhagic
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov